Display Settings:

Format

Send to:

Choose Destination
    Int J Neuropsychopharmacol. 2007 Aug;10(4):513-36. Epub 2007 Feb 21.

    White matter and cognitive function in schizophrenia.

    Source

    Department of Neuroscience, New York State Psychiatric Institute, New York, NY, USA. ajd6@columbia.edu

    Abstract

    Abnormalities of cerebral white matter, oligodendrocytes, and myelin have been observed in schizophrenia with in-vivo imaging and post-mortem biochemistry. White-matter abnormalities are also frequently associated with cognitive impairment in both healthy and diseased individuals, and cognitive dysfunction is an important component of schizophrenia. While many studies have documented these associations, only a handful have examined the role of white matter in cognitive function in schizophrenia. In this paper, we explore what is known about white-matter deficits in relation to schizophrenia, cognitive deficits, or both together, in order to generate a theoretical model for the role that compromise of white matter might play in producing cognitive impairment in schizophrenia.

    PMID:
    17313699
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Cambridge University Press

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk